Jawad Hussain Awan | Health Technology | Best Researcher Award

Published on by Health Scientists

Best Researcher Award

Jawad Hussain Awan — Iqra University
Jawad Hussain Awan
Researcher Jawad Hussain Awan
Affiliation Iqra University
Country Pakistan
Scopus ID 57189323123
Documents 8
Citations 62
h-index 4
Subject Area Health Technology
Event Health Scientists Awards

Jawad Hussain Awan is affiliated with Iqra University, Pakistan, and contributes to health technology research through scientific publications, interdisciplinary investigations, and participation in international academic communication systems. The researcher’s publication metrics and citation profile demonstrate measurable scholarly visibility within indexed healthcare and biomedical research environments.[1]

Abstract

This article presents an overview of the academic profile and scientific activities of Jawad Hussain Awan from Iqra University, Pakistan. The researcher contributes to health technology through interdisciplinary investigations, healthcare innovation studies, and indexed scientific publications. Bibliometric indicators demonstrate measurable scholarly visibility supported by citation activity and academic dissemination. Participation in scientific communication systems and healthcare-related publication platforms reflects engagement with contemporary biomedical and technological research environments. Recognition within the Health Scientists Awards framework highlights contributions to research visibility, scientific collaboration, and publication-based healthcare advancement. The profile represents ongoing participation in evidence-based health technology and academic knowledge integration.[1]

Keywords

Health Technology, Biomedical Research, Scientific Publications, Citation Analysis, Academic Recognition, Healthcare Innovation, Research Visibility, Scopus Author Profile, Health Sciences, Health Scientists Awards

Introduction

Health technology research supports healthcare advancement through scientific innovation, interdisciplinary collaboration, and evidence-based biomedical investigations. Academic researchers in this field contribute to publication systems, healthcare communication, and technological integration supporting improved research visibility and scientific dissemination internationally.[2]

Research Profile

Jawad Hussain Awan maintains an academic profile associated with health technology and biomedical publication activities. Indexed publications, citation indicators, and scholarly communication metrics demonstrate participation in healthcare-related scientific research and international academic dissemination systems supporting evidence-based technological investigations.[1]

Research Contributions

The researcher contributes to health technology through scientific publications, healthcare innovation studies, and interdisciplinary biomedical investigations. Participation in academic dissemination systems supports scholarly communication and integration of technological knowledge within healthcare-focused scientific literature and international research databases.[2]

Publications

The publication record associated with Jawad Hussain Awan includes indexed scientific articles addressing healthcare technology and biomedical innovation. Peer-reviewed publications contribute to citation visibility, academic dissemination, and participation in scholarly communication systems supporting contemporary healthcare research development.[1]

Research Impact

Research impact is reflected through publication indexing, citation metrics, and academic visibility within healthcare technology literature. Scholarly dissemination activities demonstrate measurable contribution to scientific communication systems supporting interdisciplinary biomedical and technological research advancement internationally.[1]

Award Suitability

The academic activities of Jawad Hussain Awan align with recognition criteria emphasizing publication quality, research dissemination, and healthcare technology contribution. Participation in indexed scientific communication systems demonstrates engagement with evidence-based biomedical research and scholarly visibility associated with international academic standards.[2]

Conclusion

Jawad Hussain Awan demonstrates continued involvement in health technology and biomedical research through scientific publications, scholarly communication, and interdisciplinary healthcare investigations. The academic profile reflects measurable research visibility and contribution to healthcare innovation within contemporary international scientific research environments.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Jawad Hussain Awan, Author ID 57189323123. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57189323123
  2. ResearchGate. (n.d.). ResearchGate profile of Jawad Hussain Awan.

    https://www.researchgate.net/profile/Jawad-Awan

Massimo Del Fabbro | Translational Research | Breakthrough Research Award

Published on by Health Scientists

Breakthrough Research Award

Massimo Del Fabbro
Università degli Studi di Milano, Italy
Massimo Del Fabbro
Researcher Massimo Del Fabbro
Affiliation Università degli Studi di Milano
Country Italy
Scopus ID 7004132028
Documents 584
Citations 15791
h-index 66
Subject Area Public Health
Event Health Scientists Awards
ORCID 0000-0001-7144-0984

The advancement of public health and healthcare sciences is strongly connected to the contributions of researchers whose scholarly activities support clinical innovation, evidence-based practice, and interdisciplinary scientific development. Massimo Del Fabbro, affiliated with Università degli Studi di Milano in Italy, has established a substantial academic presence through publications, citations, and collaborative healthcare investigations.[1] This article presents a structured overview of the academic profile, research contributions, and scholarly impact associated with the Breakthrough Research Award under the Health Scientists Awards initiative.[2]

Abstract

This article summarizes the scholarly achievements and academic influence of Massimo Del Fabbro in the field of public health and healthcare sciences. The overview examines publication productivity, citation indicators, institutional affiliations, and interdisciplinary scientific contributions associated with healthcare research and clinical advancement. The article additionally evaluates the relevance of these academic accomplishments within the framework of the Breakthrough Research Award presented by the Health Scientists Awards platform.[1][2]

Keywords

  • Public Health
  • Healthcare Sciences
  • Clinical Research
  • Epidemiology
  • Healthcare Innovation
  • Academic Recognition
  • Università degli Studi di Milano

Introduction

Research in public health and healthcare sciences contributes significantly to the development of clinical methodologies, healthcare management systems, and evidence-based medical practices. Recognition programs within the scientific community often emphasize the importance of sustained publication activity, citation influence, and interdisciplinary collaboration in advancing healthcare knowledge.[2] Massimo Del Fabbro has developed an extensive scholarly profile through contributions to healthcare and public health literature indexed within major academic databases. The researcher’s publication portfolio and citation performance indicate sustained scientific engagement and continued influence within healthcare-related disciplines.[1]

Research Profile

Massimo Del Fabbro is affiliated with Università degli Studi di Milano in Italy and has contributed extensively to scientific investigations related to healthcare sciences and public health. The Scopus author profile associated with Author ID 7004132028 reports 584 indexed documents, reflecting substantial research productivity and long-term academic participation.[1] The academic profile further demonstrates scholarly visibility through 15,791 citations and an h-index of 66. These indicators suggest broad dissemination of research findings and continuing recognition within the international scientific community.[1]

  • Institutional Affiliation: Università degli Studi di Milano
  • Primary Subject Area: Public Health
  • Indexed Publications: 584
  • Citation Count: 15,791
  • h-index: 66

Research Contributions

The scientific contributions associated with Massimo Del Fabbro involve clinical investigations, healthcare evaluation methodologies, epidemiological analysis, and evidence-based healthcare practices. These contributions support the advancement of medical research and provide relevant insights for healthcare professionals and policy-oriented scientific studies.[3] The researcher’s interdisciplinary collaborations and publication activities demonstrate active participation in scientific communication networks and international healthcare research initiatives.[4]

  • Clinical and healthcare research investigations
  • Public health and epidemiological analysis
  • Scientific collaboration in healthcare sciences
  • Evidence-based healthcare methodologies
  • Academic dissemination through indexed journals

Publications

The publication portfolio associated with Massimo Del Fabbro includes numerous articles indexed in internationally recognized academic databases and healthcare journals. The breadth of publications demonstrates consistent scientific activity and participation in interdisciplinary healthcare research initiatives.[1]

  1. Peer-reviewed scientific articles related to healthcare and public health sciences.
  2. Research publications indexed in Scopus and associated healthcare databases.
  3. Collaborative studies addressing healthcare innovation and clinical methodologies.
  4. Evidence-based publications supporting healthcare improvement and scientific advancement.

Research Impact

The citation metrics associated with Massimo Del Fabbro indicate substantial academic visibility and scientific influence within healthcare sciences and public health research. Citation-based indicators are commonly used to evaluate the dissemination and scholarly relevance of scientific publications across academic communities.[1] The combination of publication productivity, interdisciplinary research participation, and citation performance contributes to the researcher’s academic standing and supports continuing engagement in international scientific discourse related to healthcare innovation and evidence-based medicine.[3]

Award Suitability

The Breakthrough Research Award recognizes researchers who demonstrate sustained scientific productivity, interdisciplinary impact, and measurable scholarly influence. Based on publication activity, citation metrics, and healthcare-related research engagement, Massimo Del Fabbro demonstrates several characteristics commonly associated with scientific recognition initiatives.[2] The combination of extensive academic publications, international research visibility, and measurable citation influence supports the relevance of this recognition within the Health Scientists Awards framework and broader scientific community.[1]

Conclusion

Massimo Del Fabbro has contributed significantly to healthcare sciences and public health research through scientific publications, interdisciplinary collaboration, and evidence-based healthcare investigations. The researcher’s publication record, citation performance, and international academic visibility demonstrate continued engagement with scientific advancement and healthcare innovation. This article provides a structured academic overview associated with the Breakthrough Research Award and highlights scholarly contributions within healthcare and public health sciences.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Massimo Del Fabbro, Author ID 7004132028. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7004132028
  2. Health Scientists Awards. (n.d.). Breakthrough Research Award and Health Scientists Awards overview.
    Health Scientists Awards
  3. ORCID. (n.d.). ORCID profile of Massimo Del Fabbro.
    https://orcid.org/0000-0001-7144-0984
  4. Google Scholar. (n.d.). Google Scholar citation profile for Massimo Del Fabbro.
    https://scholar.google.com/citations?user=iaV7iGwAAAAJ&hl=en&oi=ao

  5. Capelli, M., Zuffetti, F., Del Fabbro, M., & Testori, T. Immediate rehabilitation of the completely edentulous jaw with fixed prostheses supported by either upright or tilted implants: a multicenter clinical study.

    https://pubmed.ncbi.nlm.nih.gov/17929526/

Gauthami Pulivendala | Translational Research | Young Researcher Award

Published on by Health Scientists

Dr. Gauthami Pulivendala | Translational Research | Young Researcher Award

Postdoc Associate | University of Miami | United States

Dr. Gauthami Pulivendala is a researcher at Sylvester Comprehensive Cancer Center, specializing in cancer biology, fibrosis, and molecular signaling pathways. Her work focuses on understanding mechanisms such as the ChREBPα-mediated regulation of hepatic stellate cell activation and its role in liver fibrosis, contributing to advancements in translational oncology. With 11 publications, 318 citations, and an h-index of 9, she demonstrates strong research impact and scientific productivity. Collaborating with an extensive network of co-authors, her research reflects interdisciplinary engagement across cancer biology and metabolic disease domains. Her contributions hold significant societal value by advancing knowledge in fibrosis and tumor microenvironment interactions, supporting the development of targeted therapies, and improving clinical strategies for cancer and liver-related diseases, thereby contributing to global health innovation and patient care outcomes.

Citation Metrics (Scopus)

318
240
160
80
0

Citations

318

Documents

11

h-index

9

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile

Featured Publications


Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases

– Drug Delivery and Translational Research, 2020 | Citations: 62

Showkat Ahmad Bhat | Translational Research | Editorial Board Member

Published on by Health Scientists

Dr. Showkat Ahmad Bhat | Translational Research | Editorial Board Member

Associate Professor | Deptt. of Biochemistry, Govt. Medical College Handwara | India

Dr. Showkat Ahmad Bhat is an accomplished biochemist and academic leader whose work spans clinical biochemistry, cancer biology, molecular biology, proteomics, and communicable diseases, reflecting a career dedicated to advancing both fundamental understanding and applied biomedical research. As an Associate Professor in the Department of Biochemistry at Government Medical College Handwara, he has developed a strong interdisciplinary portfolio with widely cited contributions across diverse domains, including the pharmacological potential of natural compounds, heavy metal toxicity, inflammatory mediators in metabolic disorders, animal and poultry health, and infectious disease pathogenesis. His research on bioactive phytochemicals such as zingerone, naringenin, and D-limonene has provided valuable insights into antioxidant, anti-inflammatory, and organ-protective mechanisms, while his work on microbial threats such as Salmonella, gastrointestinal parasites, and foot-and-mouth disease has informed both veterinary and public health perspectives. Dr. Bhat has collaborated extensively with national and international researchers, contributing to reviews, experimental studies, and translational investigations published in reputable journals spanning medical, veterinary, and biochemical sciences. His scholarship also extends to emerging fields such as epigenetic markers and microRNAs in breast cancer, reflecting his commitment to integrating molecular diagnostics with clinical needs. Beyond research, he has helped shape scientific understanding in the Kashmir region by addressing local health challenges, supporting capacity-building, and promoting evidence-based approaches in clinical biochemistry and infectious disease management. His cumulative body of work underscores a sustained commitment to improving human and animal health through rigorous inquiry, multidisciplinary collaboration, and the pursuit of innovative, socially relevant solutions. He has 546 citations from 28 documents with an h-index of 10.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Bilal Ahmad, S. B., Rehman, M. U., Amin, I., Arif, A., Rasool, S., … (2015). A review on pharmacological properties of zingerone (4-(4-hydroxy-3-methoxyphenyl)-2-butanone). The Scientific World Journal.

2. Bhat, S. A., Hassan, T., & Majid, S. (2019). Heavy metal toxicity and their harmful effects on living organisms: A review. International Journal of Medical Science and Diagnosis Research.

3. Dar, R. A. S. N. A. G. M. A., Ahmad, S. M., Bhat, S. A., Ahmed, R., Urwat, U., Mumtaz, P. T., … (2017). Salmonella typhimurium in poultry: A review. World’s Poultry Science Journal.

4. Bashir, A. H., Bhat, S. A., Majid, S., & Hamid, R. (2020). Role of inflammatory mediators (TNF-α, IL-6, CRP), biochemical and hematological parameters in type 2 diabetes mellitus patients of Kashmir, India. Medical Journal of the Islamic Republic of Iran.

5. Reshi, M. R. M. A., Husain, I., Bhat, S. A., Rehman, M. U., & Razak, R. (2015). Bovine mastitis as an evolving disease and its impact on the dairy industry. International Journal of Current Research and Review.

Minguk Jo | Immune Sensing | Best Researcher Award

Published on by Health Scientists

Dr. Minguk Jo| Immune Sensing| Best Researcher Award

Research Associate At University of North Carolina at Chapel Hill,United States.

Dr. Minguk Jo is a Research Associate at the University of North Carolina at Chapel Hill, specializing in immune sensing and tumor biology. His research focuses on the mechanisms of innate immune sensing, particularly the cGAS-STING pathway, and its role in cancer development and genomic stability. Dr. Jo has made significant contributions to understanding immune regulation in tumorigenesis, with several publications in high-impact journals. He has been honored with the Best Researcher Award in recognition of his outstanding work in the field. His dedication to advancing cancer immunology continues to drive innovative research at UNC Chapel Hill.

Profile:

🎓 Education

Dr. Minguk Jo holds a Ph.D. in Biochemistry and Molecular Biology from Ajou University School of Medicine, South Korea, where he completed his doctoral studies in August 2017. His academic journey began with a Bachelor of Science in Life Science from Silla University, Busan, completed in February 2010. During his undergraduate years, he actively engaged in research as an undergraduate student researcher and served as the Biological Sciences Student Council President, showcasing his early leadership and scientific curiosity. He also completed mandatory military service as a military police officer in South Korea, reflecting his discipline and commitment. Additionally, Dr. Jo broadened his academic experience with an exchange scholarship at the University of St. La Salle in 2009.

🧑‍🔬 Professional Experience

Dr. Jo is currently serving as a Research Associate at the Lineberger Comprehensive Cancer Center (LCCC), University of North Carolina at Chapel Hill (UNC-CH), a role he began in October 2024. Prior to this, he was a Postdoctoral Associate at LCCC (2020–2024) under the mentorship of Dr. Gaorav P. Gupta, where he made significant contributions to DNA damage response research. Earlier, from 2018 to 2020, he worked as a Postdoctoral Scholar at the Miller School of Medicine, University of Miami, in the lab of Dr. Glen N. Barber, specializing in innate immune responses. His professional career also includes a Research Associate role at Ajou University (2017–2018), where he contributed to molecular biology research and served as a Teaching Assistant for laboratory courses in 2016 and 2017. His leadership extended into mentoring, having supervised multiple Ph.D. students, postdocs, and undergraduate researchers throughout his career.

🛠️ Skills and Expertise

Dr. Jo’s research expertise lies at the intersection of DNA damage response, innate immunity, chromatin dynamics, and cancer biology. He is particularly skilled in dissecting the molecular mechanisms of the cGAS-STING pathway, exploring how DNA damage sensing translates into immune activation — a critical avenue for therapeutic development in oncology. His technical competencies span cell biology, molecular biology, biochemistry, DNA repair assays, immune signaling, and translational cancer research. He is also experienced in academic mentoring, grant writing, and scientific communication, as evidenced by his roles in teaching, student supervision, and active participation in scientific societies.

🏆 Honors and Awards

Dr. Jo has been recognized with numerous prestigious awards throughout his career. Most notably, he secured the NIH/NCI K22 Career Development Award (2026–2029) with an exceptional score of 18, underscoring his promising trajectory as an independent investigator. His other accolades include the FAOBMB Travel Award (2025), the Joseph S. Pagano Award (2024), and the James A. Raleigh Award for Excellence in Biology Research (2023) at UNC-CH. He was also a recipient of the Young Scientist Award (2017) from the Korean Society for Molecular and Cellular Biology and an EMBO Travel Grant awardee for his oral presentation on redox biology. His consistent academic excellence is further highlighted by multiple Dean’s Honor Scholarships and early career travel awards, including recognition by the American Society for Cell Biology (ASCB).

🔬 Research Focus

Dr. Jo’s research is centered on understanding the mechanisms of MRE11-mediated cGAS activation in DNA sensing, particularly within the context of cancer. His NIH/NCI-funded project aims to unravel how MRE11 facilitates the release and activation of cGAS, promoting immune responses against DNA-damaged cells — a process critical for anti-cancer immunity. His broader research scope covers the regulation of chromosomal stability, DNA repair pathways, and the cross-talk between genome integrity and innate immunity. With over a dozen peer-reviewed publications in high-impact journals like Nature, Molecular Cell, and DNA Repair, Dr. Jo continues to push the frontiers of translational cancer research. His work not only deepens our molecular understanding but also paves the way for innovative therapeutic strategies targeting immune responses in cancer.

Publication Top Notes

  • The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels
    A Basit, MG Cho, EY Kim, D Kwon, SJ Kang, JH Lee
    Experimental & Molecular Medicine 52 (4), 643-657
    Citations: 106
    Year: 2020

 

  • MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis
    MG Cho, RJ Kumar, CC Lin, JA Boyer, JA Shahir, K Fagan-Solis, …
    Nature 625 (7995), 585-592
    Citations: 70
    Year: 2024

 

  • Dual inhibition of DNA-PK and DNA polymerase theta overcomes radiation resistance induced by p53 deficiency
    RJ Kumar, HX Chao, DA Simpson, W Feng, MG Cho, VR Roberts, …
    NAR Cancer 2 (4), zcaa038
    Citations: 27
    Year: 2020

 

  • ATP depletion during mitotic arrest induces mitotic slippage and APC/C^Cdh1-dependent cyclin B1 degradation
    YY Park, JH Ahn, MG Cho, JH Lee
    Experimental & Molecular Medicine 50 (4), 1-14
    Citations: 26
    Year: 2018

 

  • A putative pH-dependent nuclear localization signal in the juxtamembrane region of c-Met
    SC Chaudhary, MG Cho, TT Nguyen, KS Park, MH Kwon, JH Lee
    Experimental & Molecular Medicine 46 (10), e119-e119
    Citations: 17
    Year: 2014

 

  • DNA double-strand breaks and Aurora B mislocalization induced by exposure of early mitotic cells to H2O2 appear to increase chromatin bridges and resultant cytokinesis failure
    MG Cho, JH Ahn, HS Choi, JH Lee
    Free Radical Biology and Medicine 108, 129-145
    Citations: 15
    Year: 2017

 

  • Inhibition of PP2A activity by H2O2 during mitosis disrupts nuclear envelope reassembly and alters nuclear shape
    JH Ahn, MG Cho, S Sohn, JH Lee
    Experimental & Molecular Medicine 51 (6), 1-18
    Citations: 12
    Year: 2019

Conclusion

trong Candidate for a “Best Researcher Award”, particularly in Early-Career or Young Investigator categories.With his momentum in securing competitive funding, high-impact publications, and growing leadership in research, Dr. Minguk Jo demonstrates clear potential for long-term excellence in biomedical research. Continuous growth in independent leadership roles and broader scientific contributions will only strengthen his future candidacy.